Michael P. Wilson
Research Subjects
Michael P. Wilson has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Gary M. Vilke
University of California at San Diego Medical Center, San Diego, California; Department of Emergency Medicine Behavioral Emergencies Research (DEMBER) Laboratory, University of California San Diego, San Diego, California
5 shared publicationsKimberly Nordstrom
Department of Psychiatry, University of Colorado School of Medicine, 1890 N Revere Ct, Aurora, Colorado, USA
5 shared publicationsEdward M. Castillo
Department of Emergency Medicine Behavioral Emergencies Research (DEMBER) lab, University of California San Diego, San Diego, CA; Department of Emergency Medicine, University of California San Diego, San Diego, CA
3 shared publications- Angie Waliski
Department of Health Services Research and Development, Central Arkansas Veteran’s Healthcare System, North Little Rock, AR, USA
2 shared publications Arpi Minassian
2 shared publications- David Feifel
Department of Psychiatry, University of California, San Diego Medical Center, San Diego, USA
2 shared publications
Latest Publications
- Open Access
- 17 October 2026
- Published by Springer Nature in BMC Medicine
International Delphi on a medical screening tool for emergency department patients with psychiatric complaints
Background: Medical screening in the emergency department (ED) is performed to identify underlying medical conditions that may contribute to a patient’s psychiatric presentation and/or require treatment. This process frequently causes disagreement between emergency physicians and psychiatrists regarding objectives and scope of medical screening, leading to potentially unnecessary testing, prolonged ED length-of-stay, and increased costs. This study aims to develop an evidence-informed and consensus-based medical screening tool through a transdisciplinary, international Delphi process. Methods: This modified international Delphi study was conducted between May and November 2025 using a 4-round modified Delphi process with online surveys and online steering committee discussions. Participants included 25 society representatives from 7 emergency medicine and psychiatry societies across 4 continents and 6 patient representatives with prior ED medical screening experience as patients or patient relatives. Participants generated, rated, refined, and reached consensus on proposed screening elements. Consensus was predefined as ≥80% agreement in Round 3. In Round 4, the resulting tool was applied to 37 standardized clinical vignettes. Interrater agreement was assessed using Gwet agreement coefficient (AC). Results: Of 28 invited society representatives and steering committee members, 25 (89.3%) participated in Round 1, 23 (82.1%) in Round 2, 22 (78.6%) in Round 3, and 23 (82.1%) in Round 4. The 6 patient representatives completed all 4 rounds. In Round 1, participants generated 91 statements from society representatives and 27 from patient representatives. Following refinement in Round 2, consensus in Round 3 was achieved for 48 of 91 society representatives’ statements (52.8%) and 21 of 27 patient statements (77.8%), which were synthesized into the Delphi-Informed Medical Evaluation (DIME) tool. In Round 4, application of the draft DIME tool to 37 clinical vignettes demonstrated almost perfect agreement among society representatives (Gwet AC, 0.86; 95%-CI 0.78–0.93; p < .001) and substantial agreement among patient representatives (Gwet AC, 0.76; 95%-CI 0.66–0.86; p < .001). Conclusions: This international modified Delphi study developed the DIME tool, a consensus-based medical screening tool to identify adult ED patients with psychiatric complaints who are at low risk for acute medical illness. Prospective multicenter validation studies are required before clinical implementation. Trial registration: clinicaltrials.gov, NCT06936826
- 17 October 2026
- Published by Springer Nature in BMC Medicine
Open AccessInternational Delphi on a medical screening tool for emergency department patients with psychiatric complaints
Background: Medical screening in the emergency department (ED) is performed to identify underlying medical conditions that may contribute to a patient’s psychiatric presentation and/or require treatment. This process frequently causes disagreement between emergency physicians and psychiatrists regarding objectives and scope of medical screening, leading to potentially unnecessary testing, prolonged ED length-of-stay, and increased costs. This study aims to develop an evidence-informed and consensus-based medical screening tool through a transdisciplinary, international Delphi process. Methods: This modified international Delphi study was conducted between May and November 2025 using a 4-round modified Delphi process with online surveys and online steering committee discussions. Participants included 25 society representatives from 7 emergency medicine and psychiatry societies across 4 continents and 6 patient representatives with prior ED medical screening experience as patients or patient relatives. Participants generated, rated, refined, and reached consensus on proposed screening elements. Consensus was predefined as ≥80% agreement in Round 3. In Round 4, the resulting tool was applied to 37 standardized clinical vignettes. Interrater agreement was assessed using Gwet agreement coefficient (AC). Results: Of 28 invited society representatives and steering committee members, 25 (89.3%) participated in Round 1, 23 (82.1%) in Round 2, 22 (78.6%) in Round 3, and 23 (82.1%) in Round 4. The 6 patient representatives completed all 4 rounds. In Round 1, participants generated 91 statements from society representatives and 27 from patient representatives. Following refinement in Round 2, consensus in Round 3 was achieved for 48 of 91 society representatives’ statements (52.8%) and 21 of 27 patient statements (77.8%), which were synthesized into the Delphi-Informed Medical Evaluation (DIME) tool. In Round 4, application of the draft DIME tool to 37 clinical vignettes demonstrated almost perfect agreement among society representatives (Gwet AC, 0.86; 95%-CI 0.78–0.93; p < .001) and substantial agreement among patient representatives (Gwet AC, 0.76; 95%-CI 0.66–0.86; p < .001). Conclusions: This international modified Delphi study developed the DIME tool, a consensus-based medical screening tool to identify adult ED patients with psychiatric complaints who are at low risk for acute medical illness. Prospective multicenter validation studies are required before clinical implementation. Trial registration: clinicaltrials.gov, NCT06936826
- 6 July 2026
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 88, 256-269
Agitation: A Clinical Review for Emergency Medicine Physicians
- 6 July 2026
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 88, 256-269
Agitation: A Clinical Review for Emergency Medicine Physicians
- 11 October 2025
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 78, 402-403
Reply to Letter to the Editor
- 11 October 2025
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 78, 402-403
Reply to Letter to the Editor
- 5 August 2025
- Published by Hogrefe Publishing Group in Crisis
Peer-Delivered Written Versus Electronic Suicide Safety Planning in the Emergency Department
Background: Suicide is one of the leading causes of death in the United States, and safety planning is a best practice to reduce the risk of suicide. It is currently unknown if electronic safety planning with a phone app results in effective safety planning compared to paper versions. Aims: To evaluate electronic safety planning vs. a paper safety plan in the ED setting. Methods: A pilot randomized controlled trial was conducted in which 30 participants were randomized 1:1 into traditional paper safety planning versus safety planning on a phone app (My3). Outcomes of interest included safety plan completeness, safety plan quality, and return ED visits within 3 months. Findings/Results: Despite taking less time to complete, paper safety planning was more complete than electronic safety planning. There were no significant differences in quality or return ED visits within 3 months. Limitations: This study was limited to a small sample size by our local IRB. Conclusions: Given that plan completeness has previously shown mixed associations with clinical outcomes, further research is needed to refine and evaluate electronic formats.
- 5 August 2025
- Published by Hogrefe Publishing Group in Crisis
Peer-Delivered Written Versus Electronic Suicide Safety Planning in the Emergency Department
Background: Suicide is one of the leading causes of death in the United States, and safety planning is a best practice to reduce the risk of suicide. It is currently unknown if electronic safety planning with a phone app results in effective safety planning compared to paper versions. Aims: To evaluate electronic safety planning vs. a paper safety plan in the ED setting. Methods: A pilot randomized controlled trial was conducted in which 30 participants were randomized 1:1 into traditional paper safety planning versus safety planning on a phone app (My3). Outcomes of interest included safety plan completeness, safety plan quality, and return ED visits within 3 months. Findings/Results: Despite taking less time to complete, paper safety planning was more complete than electronic safety planning. There were no significant differences in quality or return ED visits within 3 months. Limitations: This study was limited to a small sample size by our local IRB. Conclusions: Given that plan completeness has previously shown mixed associations with clinical outcomes, further research is needed to refine and evaluate electronic formats.
- 10 May 2025
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 79, 639-645
A Case Report of Headache and Weakness Diagnosed as Functional Neurological Disorder
- 10 May 2025
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 79, 639-645
A Case Report of Headache and Weakness Diagnosed as Functional Neurological Disorder
- 8 February 2023
- Published by Springer Nature
- p. 1-17
Assessment and Management of Agitation
- 17 January 2023
- Published by Elsevier in Journal of Emergency Nursing
- Vol. 49 (2) , 255-265
Emergency Departments Treating Veterans for Suicide: Ensuring Quality Care for Veterans Outside of Department of Veterans Affairs Health Care Facilities
- 17 January 2023
- Published by Elsevier in Journal of Emergency Nursing
- Vol. 49 (2) , 255-265
Emergency Departments Treating Veterans for Suicide: Ensuring Quality Care for Veterans Outside of Department of Veterans Affairs Health Care Facilities
- 13 December 2018
- Published by Wiley in Academic Emergency Medicine
- Vol. 26 (5) , 559-566
Study Enrollment When “Preconsent” Is Utilized for a Randomized Clinical Trial of Two Treatments for Acute Agitation in the Emergency Department
Background: Acute agitation in the emergency department (ED) represents a danger to both patients and their caregivers. Medication is often needed, and few high‐quality randomized trials have evaluated the optimal drugs for this vulnerable population. In the United States, as of 2017, randomized trials of drugs typically cannot be conducted under Waiver of Consent (46 CFR 45.116), and Exception From Informed Consent trials (21 CFR 50.24) are limited to life‐threatening conditions, are onerous, and require filing an investigational new drug application with the FDA. We sought to conduct a randomized double‐dummy trial of inhaled loxapine versus intramuscular haloperidol + lorazepam for acute agitation in the ED by obtaining consent in advance (“preconsent”) in patients at risk of future agitation, allowing study drug administration up to 3 years later if the patient presented with acute agitation.Objective: We sought to report the successful enrollment rate of patients preconsented at an earlier ED visit for this trial.Methods: This was an analysis of patients age 18 to 64 with bipolar I disorder or schizophrenia preconsented for enrollment in the trial (clinicaltrials.gov, NCT02877108) conducted at a single urban academic center seeing approximately 60,000 patients per year. Eligible patients were assessed for capacity to consent by trained research associates, and informed consent was obtained at an ED visit for the possibility of administering drugs for agitation within the next 3 years. In the event the patient later presented to the ED and the attending physician deemed the patient required treatment for acute agitation, preconsent was confirmed and study drug would be administered.Results: Over 67 days, 1,461 patients were screened in the ED, 269 had bipolar I or schizophrenia, 194 of whom had a contraindication to inhaled loxapine leaving 75 eligible patients; preconsent was obtained in 43 patients. Four additional patients who had not preconsented were consented for the trial in real time (three by surrogate, one patient had capacity while agitated) resulting in a total of 47 consented patients. Of these 47, a total of 12 were later removed from the study: 10 patients had unrecognized exclusion criteria for inhaled loxapine, one preconsented patient contacted the investigators at a later date and asked to be removed, and one surrogate revoked consent immediately after providing it. Only two patients were successfully enrolled, neither by preconsent: one was enrolled via a surrogate the day of enrollment, and the other was mildly agitated and had capacity to consent. The remaining patient with a valid surrogate consent did not receive study medication.Conclusions: Utilization of preconsent to enroll patients in a randomized trial of treatments for acute agitation in the ED requires substantial resources and may not be feasible.
- 13 December 2018
- Published by Wiley in Academic Emergency Medicine
- Vol. 26 (5) , 559-566
Study Enrollment When “Preconsent” Is Utilized for a Randomized Clinical Trial of Two Treatments for Acute Agitation in the Emergency Department
Background: Acute agitation in the emergency department (ED) represents a danger to both patients and their caregivers. Medication is often needed, and few high‐quality randomized trials have evaluated the optimal drugs for this vulnerable population. In the United States, as of 2017, randomized trials of drugs typically cannot be conducted under Waiver of Consent (46 CFR 45.116), and Exception From Informed Consent trials (21 CFR 50.24) are limited to life‐threatening conditions, are onerous, and require filing an investigational new drug application with the FDA. We sought to conduct a randomized double‐dummy trial of inhaled loxapine versus intramuscular haloperidol + lorazepam for acute agitation in the ED by obtaining consent in advance (“preconsent”) in patients at risk of future agitation, allowing study drug administration up to 3 years later if the patient presented with acute agitation.Objective: We sought to report the successful enrollment rate of patients preconsented at an earlier ED visit for this trial.Methods: This was an analysis of patients age 18 to 64 with bipolar I disorder or schizophrenia preconsented for enrollment in the trial (clinicaltrials.gov, NCT02877108) conducted at a single urban academic center seeing approximately 60,000 patients per year. Eligible patients were assessed for capacity to consent by trained research associates, and informed consent was obtained at an ED visit for the possibility of administering drugs for agitation within the next 3 years. In the event the patient later presented to the ED and the attending physician deemed the patient required treatment for acute agitation, preconsent was confirmed and study drug would be administered.Results: Over 67 days, 1,461 patients were screened in the ED, 269 had bipolar I or schizophrenia, 194 of whom had a contraindication to inhaled loxapine leaving 75 eligible patients; preconsent was obtained in 43 patients. Four additional patients who had not preconsented were consented for the trial in real time (three by surrogate, one patient had capacity while agitated) resulting in a total of 47 consented patients. Of these 47, a total of 12 were later removed from the study: 10 patients had unrecognized exclusion criteria for inhaled loxapine, one preconsented patient contacted the investigators at a later date and asked to be removed, and one surrogate revoked consent immediately after providing it. Only two patients were successfully enrolled, neither by preconsent: one was enrolled via a surrogate the day of enrollment, and the other was mildly agitated and had capacity to consent. The remaining patient with a valid surrogate consent did not receive study medication.Conclusions: Utilization of preconsent to enroll patients in a randomized trial of treatments for acute agitation in the ED requires substantial resources and may not be feasible.
- 1 July 2016
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 51 (1) , 66-69
Psychiatric Emergencies for Clinicians: Emergency Department Management of Neuroleptic Malignant Syndrome
- 1 July 2016
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 51 (1) , 66-69
Psychiatric Emergencies for Clinicians: Emergency Department Management of Neuroleptic Malignant Syndrome
- 1 January 2016
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 50 (1) , 89-91
Psychiatric Emergencies for Clinicians: Emergency Department Management of Serotonin Syndrome
- 1 January 2016
- Published by Elsevier in The Journal of Emergency Medicine
- Vol. 50 (1) , 89-91
Psychiatric Emergencies for Clinicians: Emergency Department Management of Serotonin Syndrome